semaglutide hospitalization Real-world outcomes for GLP‑1 therapies in HFpEF and T2DM published in @JAMA_current: In >97k U.S. patients, & tirzepatide each reduced HF hospitalization/all-cause mortality by >40% vs sitagliptin — confirming STEP‑HFpEF DM Semaglutide vs Tirzepatide in HFpEF
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25



























